Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Cansortium Inc (CNTMF)

Cansortium Inc (CNTMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cansortium Announces Shares for Debt Settlement Newswire.ca - Fri Jun 2, 2023

/CNW/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated cannabis company operating under the Fluent™...

TIUM-U.CN : 0.1700 (-2.86%)
CNTMF : 0.1760 (+1.85%)
Cansortium Announces Shares for Debt Settlement PR Newswire - Fri Jun 2, 2023

/PRNewswire/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated cannabis company operating under the...

TIUM-U.CN : 0.1700 (-2.86%)
CNTMF : 0.1760 (+1.85%)
Cansortium Reports First Quarter 2023 Results PR Newswire - Wed May 31, 2023

/PRNewswire/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating...

TIUM-U.CN : 0.1700 (-2.86%)
CNTMF : 0.1760 (+1.85%)
Cansortium Reports First Quarter 2023 Results Newswire.ca - Wed May 31, 2023

/CNW/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the...

TIUM-U.CN : 0.1700 (-2.86%)
CNTMF : 0.1760 (+1.85%)
FLUENT Issues Statement on Failed Cannabis Bills in Texas Newswire.ca - Fri May 26, 2023

/CNW/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the...

TIUM-U.CN : 0.1700 (-2.86%)
CNTMF : 0.1760 (+1.85%)
FLUENT Issues Statement on Failed Cannabis Bills in Texas PR Newswire - Fri May 26, 2023

/PRNewswire/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating...

TIUM-U.CN : 0.1700 (-2.86%)
CNTMF : 0.1760 (+1.85%)
FLUENT Launches Cannabis-Infused Dark Chocolate Bar in Florida PR Newswire - Wed May 24, 2023

/PRNewswire/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company operating under...

CNTMF : 0.1760 (+1.85%)
FLUENT Launches Cannabis-Infused Dark Chocolate Bar in Florida Newswire.ca - Wed May 24, 2023

/CNW/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the...

CNTMF : 0.1760 (+1.85%)
Cansortium Schedules First Quarter 2023 Conference Call for Wednesday, May 31 at 4:30 P.M. ET PR Newswire - Tue May 23, 2023

/PRNewswire/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating...

TIUM-U.CN : 0.1700 (-2.86%)
CNTMF : 0.1760 (+1.85%)
Cansortium Schedules First Quarter 2023 Conference Call for Wednesday, May 31 at 4:30 P.M. ET Newswire.ca - Tue May 23, 2023

/CNW/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the...

TIUM-U.CN : 0.1700 (-2.86%)
CNTMF : 0.1760 (+1.85%)

Barchart Exclusives

1 'Strong Buy' Dividend Stock to Buy and Hold Barchart - Mon May 13, 6:30PM CDT
Discover why Eli Lilly is considered a 'strong buy' as it capitalizes on the growing demand for diabetes and obesity treatments, backed by its robust financial performance and promising future prospects. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot